Adam S. Grossman, President and CEO at ADMA BIOLOGICS, INC. (ADMA), sold 1,252,490 shares at $17.69 ($21.8M) on 2024-08-26, disclosed to the SEC on 2024-08-27.
Open-market sale of $21.8M ADMA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.69 | 236,889 | $4.2M | 19.2% |
| 2 | $17.69 | 236,889 | $4.2M | 19.2% |
| 3 | $17.29 | 389,356 | $6.7M | 30.8% |
| 4 | $17.29 | 389,356 | $6.7M | 30.8% |
| Total | $17.44 avg | 1,252,490 | $21.8M | 100% |
| Filing → |
| ADMA | SELL | 2025-12-16 | $416K | — | Filing → |
| ADMA | SELL | 2025-11-21 | $336K | — | Filing → |
| ADMA | SELL | 2025-10-24 | $336K | — | Filing → |